Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Copyright Clearance Center Wins 2023 European Best of Show Award for Scientific Article Exploration Tool

    Nov 30, 2023, 09:45 AM by User Not Found
    Bio-IT World | The Bio-IT World community has chosen the 2023 Best of Show Awards Europe winner. The more than 300 event attendees in London were invited to vote for their favorite solutions, and they chose to honor RightFind XML from Copyright Clearance Center (CCC) as the 2023 honoree.
    Full story
  • Ardena's new Aseptic Fill-Finish Plant in Ghent receives GMP license

    Nov 30, 2023, 09:12 AM by
    Full story
  • Sygnature Discovery appoints new industry leaders to their board of directors

    Nov 30, 2023, 09:12 AM by
    I'm getting in touch with the latest news from Sygnature Discovery, a world-leading contract research organization. The company has recently appointed two industry leaders, Vanessa Malier and Martin LeBlanc, to their board of directors, reinforcing its commitment to innovation and strategic leadership. With decades of experience and a wealth of expertise in their respective fields, both Martin and Vanessa bring unique and valuable perspectives to Sygnature Discovery's board. Further details can be found in the press release below. I have also attached headshots of both Vanessa and Martin to this email. Please let me know if you have any questions or if you require any further information. Many thanks, Charlotte
    Full story
  • CD Genomics Takes Genomic Research to New Heights with Ribo-seq Technology

    Nov 30, 2023, 09:12 AM by
    Full story
  • CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward

    Nov 30, 2023, 09:12 AM by
    Full story
  • CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service

    Nov 30, 2023, 09:12 AM by
    Full story
  • Ventric Health Named Best Digital/Mobile Health Solution in the Fierce Healthcare Innovation Awards 2023 for Its Vivio System™

    Nov 30, 2023, 09:12 AM by
    Ventric Health Named Best Digital/Mobile Health Solution in the Fierce Healthcare Innovation Awards 2023 for Its Vivio System™
    Full story
  • Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

    Nov 30, 2023, 09:12 AM by
    Full story
  • Follow the Money: AI-Designed De Novo Therapeutics, Spatial Technology, DNA Platform for Rheumatoid Arthritis, More

    Nov 30, 2023, 01:00 AM by User Not Found
    Bio-IT World | Absci and Almirall announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases; Stellaromics is developing next-generation spatial technology that promises to accelerate the development of fundamentally novel drug treatments, including for autoimmune diseases, cancer, and more; Aqtual intends to expand its platform that evaluates protein regulation, epigenetics, and transcriptomics; more.
    Full story
  • InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference

    Nov 29, 2023, 08:32 AM by
    InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference
    Full story
  • "Prescribing the Future: 503A U.S. Compounding Pharmacies Market Soars to $7.18 Billion by 2032, Fueled by Surging Demand for Personalized Healthcare"

    Nov 29, 2023, 08:32 AM by
    The 503A U.S. compounding pharmacies market is not just witnessing growth; it's shaping the future of personalized healthcare. As demand intensifies, regulatory challenges persist, and innovative solutions emerge, these pharmacies stand at the intersection of patient-centric care and technological advancement, promising a transformative journey ahead.
    Full story
  • Improving the Patient Experience With AI-Powered Medication History That Helps Streamline Admissions at Southlake Regional Health Centre

    Nov 29, 2023, 08:32 AM by
    DrFirst Healthcare Innovations has partnered with Southlake Regional Health Centre
    Full story
  • Exothera’s CTO Patrick Thiaville nominated as a member of Alliance for mRNA Medicines Board

    Nov 29, 2023, 08:32 AM by
    Exothera has announced its Nucleic Acids Chief Technology Officer, Patrick Thiaville has been nominated as a member of the Alliance for mRNA Medicines (AMM) board.
    Full story
  • Greenphire, Florence Healthcare Team Up; Illumina Partnerships; Oxford Nanopore Develops New Data Technology

    Nov 29, 2023, 01:00 AM by User Not Found
    Bio-IT World | Greenphire and Florence Healthcare announce a technology partnership; Illumina and Veracyte join together in a multi-year agreement; Oxford Nanopore Technologies collaborates with Fabric Genomics and Saphetor to develop data technology for research; more.
    Full story
  • Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fourth Consecutive Year

    Nov 28, 2023, 09:02 AM by
    Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fourth Consecutive Year
    Full story
  • Profacgen Updates Its Fermentation Process Development Solutions

    Nov 28, 2023, 09:02 AM by
    Full story
  • Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

    Nov 28, 2023, 09:02 AM by
    Full story
  • Matexcel Enlarged Its Offerings for Bioglass Products

    Nov 28, 2023, 09:02 AM by
    Full story
  • Lifeasible Enhanced Its Plant Metabolite Profiling Services

    Nov 28, 2023, 09:01 AM by
    Full story
  • Creative Enzymes Unveils Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing

    Nov 28, 2023, 09:01 AM by
    Full story
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56 (current)
  • 57
  • 58
  • 59
  • 60
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy